Your browser doesn't support javascript.
loading
PTEN loss promotes Warburg effect and prostate cancer cell growth by inducing FBP1 degradation.
Song, Changze; Zhang, Jianong; Liu, Xiao; Li, Meilu; Wang, Dejie; Kang, Zhijian; Yu, Jiaao; Chen, Jiuwei; Pan, Hongxin; Wang, Honglei; Li, Guangbin; Huang, Haojie.
Afiliación
  • Song C; Department of Urology, The Fourth Hospital of Harbin Medical University, Harbin Medical University, Harbin, China.
  • Zhang J; Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, United States.
  • Liu X; Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, United States.
  • Li M; Department of Urology, The Fourth Hospital of Harbin Medical University, Heilongjiang Key Laboratory of Scientific Research in Urology, Harbin, China.
  • Wang D; National Health Commission (NHC) Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, Harbin Medical University, Harbin, China.
  • Kang Z; Department of Dermatology, The Second Hospital of Harbin Medical University, Harbin Medical University, Harbin, China.
  • Yu J; Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, United States.
  • Chen J; Department of Urology, The Fourth Hospital of Harbin Medical University, Heilongjiang Key Laboratory of Scientific Research in Urology, Harbin, China.
  • Pan H; National Health Commission (NHC) Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, Harbin Medical University, Harbin, China.
  • Wang H; Department of Urology, The Fourth Hospital of Harbin Medical University, Heilongjiang Key Laboratory of Scientific Research in Urology, Harbin, China.
  • Li G; National Health Commission (NHC) Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, Harbin Medical University, Harbin, China.
  • Huang H; Department of Urology, The Fourth Hospital of Harbin Medical University, Heilongjiang Key Laboratory of Scientific Research in Urology, Harbin, China.
Front Oncol ; 12: 911466, 2022.
Article en En | MEDLINE | ID: mdl-36237339
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China